Publication | Closed Access
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports
11
Citations
5
References
2021
Year
Surgical OncologyMedicineImmunologyPathologyCase ReportsImmune Checkpoint InhibitorPd-1 InhibitorAnti-cancer AgentCancer TreatmentImmunotherapyOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1